New national guidelines are being rolled out to remove inconsistencies in the way community pharmacies handle over-the-counter (OTC) asthma reliever medication.
The guidelines were developed after University of WA PhD researcher Carl Schneider identified discrepancies in the approaches taken by different pharmacists to advising patients on asthma medication.
The new Asthma Action Plan and Beta Agonist Guidelines for pharmacists have already been introduced in WA. They are now set to be rolled out nationally, said Professor Kim Watkins from the University of WA and project officer in charge of the launch.
“Integral to the guidelines was the need for patients to be referred to a medical practitioner if they did not have a written asthma action plan.
“This lead researchers to collaborate with the...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.